News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,744 Results
Type
Article (50310)
Company Profile (361)
Press Release (669073)
Section
Business (210843)
Career Advice (2213)
Deals (36370)
Drug Delivery (98)
Drug Development (83354)
Employer Resources (176)
FDA (16778)
Job Trends (15362)
News (356625)
Policy (34043)
Tag
Academia (2755)
Alliances (51387)
Alzheimer's disease (1268)
Approvals (16702)
Artificial intelligence (142)
Bankruptcy (363)
Best Places to Work (11904)
Biotechnology (267)
Breast cancer (124)
Cancer (1134)
Cardiovascular disease (101)
Career advice (1847)
Cell therapy (248)
Clinical research (65936)
Collaboration (407)
Compensation (201)
COVID-19 (2668)
C-suite (100)
Data (1142)
Diabetes (153)
Diagnostics (6366)
Earnings (86567)
Employer resources (155)
Events (113743)
Executive appointments (317)
FDA (17329)
Funding (364)
Gene therapy (203)
GLP-1 (619)
Government (4523)
Healthcare (19377)
Infectious disease (2755)
Inflammatory bowel disease (109)
Interviews (360)
IPO (16622)
Job creations (3851)
Job search strategy (1572)
Layoffs (443)
Legal (8406)
Lung cancer (184)
Manufacturing (183)
Medical device (13488)
Medtech (13493)
Mergers & acquisitions (19820)
Metabolic disorders (427)
Neuroscience (1562)
NextGen Class of 2024 (6802)
Non-profit (4701)
Northern California (1502)
Obesity (250)
Opinion (219)
Patents (108)
People (58485)
Phase I (20576)
Phase II (29014)
Phase III (21616)
Pipeline (467)
Postmarket research (2663)
Preclinical (8948)
Radiopharmaceuticals (244)
Rare diseases (239)
Real estate (6128)
Regulatory (22440)
Research institute (2512)
Resumes & cover letters (377)
Southern California (1318)
Startups (3789)
United States (13822)
Vaccines (592)
Weight loss (189)
Date
Today (3)
Last 7 days (687)
Last 30 days (3662)
Last 365 days (36715)
2024 (33713)
2023 (41133)
2022 (52406)
2021 (57007)
2020 (55445)
2019 (48203)
2018 (36446)
2017 (33642)
2016 (33231)
2015 (39239)
2014 (32856)
2013 (31004)
2012 (30423)
2011 (30896)
2010 (29032)
Location
Africa (816)
Arizona (196)
Asia (40222)
Australia (6721)
California (3404)
Canada (1301)
China (260)
Colorado (149)
Connecticut (159)
Europe (88836)
Florida (466)
Georgia (117)
Illinois (359)
Indiana (200)
Kansas (97)
Maryland (584)
Massachusetts (2697)
Michigan (160)
Minnesota (285)
New Jersey (973)
New York (980)
North Carolina (738)
Northern California (1502)
Ohio (142)
Pennsylvania (858)
South America (1196)
Southern California (1318)
Texas (476)
Utah (93)
Washington State (377)
719,744 Results for "trucode gene repair inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Precision BioSciences Presents Preclinical Data Highlighting the Capability of ARCUS for High-Efficiency Gene Editing Utilizing Homology-Directed Repair at the ESGCT 31st Annual Congress
October 24, 2024
·
9 min read
Press Releases
Heart Repair Technologies, Inc. Appoints David H. Chung as Chief Executive Officer
October 28, 2024
·
3 min read
Pipeline
Neurogene Drops Batten Gene Therapy Program
After failing to receive the RMAT designation from the FDA for its early-stage Batten disease gene therapy, Neurogene tells investors that it’s evaluating options for the program.
November 19, 2024
·
2 min read
·
Kate Goodwin
Approvals
PTC Wins First FDA Nod for Direct-to-Brain Gene Therapy, Targets Ultrarare Disease
The FDA has followed in the footsteps of its European counterparts and granted accelerated approval to PTC Therapeutics’ gene therapy Kebilidi for AADC deficiency. It is the first approved gene therapy to be delivered directly to the brain.
November 14, 2024
·
2 min read
·
Tristan Manalac
Pharm Country
Repair Biotechnologies Demonstrates Rapid Reversal of Atherosclerosis in Mouse Models
Repair Biotechnologies, Inc. announced today that its lipid nanoparticle (LNP)/messenger RNA (mRNA) therapy has rapidly reversed the progression of atherosclerosis in mouse models applicable to both the rare genetic condition of familial hypercholesterolemia as well as atherosclerosis in the broader population.
April 2, 2024
·
3 min read
Press Releases
Avirmax Inc. to Present at the ARVO Frontiers in Ocular Gene Therapy Research Conference
November 12, 2024
·
2 min read
BioMidwest
Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System
Paragon 28, Inc., is pleased to announce the launch of the Grappler® R3INFORCE™ Extraosseous Repair System designed to restore stability to the anterior and posterior ligaments surrounding the ankle during fibula fracture repairs and high ankle sprains.
March 28, 2024
·
5 min read
Pharm Country
ANEW MEDICAL, INC. Secures Key Patent in Europe for Human Klotho Gene RNA Slice Variant and Protein
ANEW MEDICAL, INC. announces that is has been granted and issued a patent in Europe, EP3377091B1, for the use of ANEW’s secreted Klotho gene sequence and gene delivery systems to be used in the treatment of diminished cognition, memory loss, dementia and other neurodegenerative diseases.
June 26, 2024
·
4 min read
Duchenne muscular dystrophy
Regenxbio Gears Up to Challenge Sarepta in DMD as Gene Therapy Advances to Pivotal Studies
Regenxbio is pushing its Duchenne muscular dystrophy gene therapy into pivotal development, with a BLA planned for 2026—potentially posing a threat to Sarepta’s Elevidys.
November 19, 2024
·
2 min read
·
Tristan Manalac
Gene therapy
Neurogene Details Gene Therapy Complication, Sending Shares Plummeting Again
Neurogene’s shares fell by 36% as the market opened Monday morning following news that a patient experienced systemic hyperinflammatory syndrome in a Phase I/II clinical trial of Rett syndrome gene therapy NGN-401.
November 18, 2024
·
2 min read
·
Annalee Armstrong
1 of 71,975
Next
